Thursday, 5 March, 2026
Verily Cuts Jobs, Shutters Medical Devices Program to Focus on AI
By Isha
Verily, Alphabet’s life-sciences “moonshot” division, has initiated another round of layoffs while shutting down its medical devices program to streamline operations and better align with strategic goals. CEO Stephen Gillett, in a memo to staff, expressed gratitude to affected employees and outlined continued support—including severance and career assistance. The restructuring reflects a broader pivot toward AI, precision health, and scalable data platforms for long-term commercial success.
Read full story at Economic Times